Tysabri Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials

Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants
Condition:   Relapsing Remitting Multiple Sclerosis Intervention:   Drug: Natalizumab Sponsor:   Biogen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2021 Category: Research Source Type: clinical trials

Comparing the Safety and Benefit of Natalizumab (Tysabri ®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
Condition:   Multiple Sclerosis (MS) Intervention:   Other: At-home natalizumab treated MS patient Sponsors:   Nantes University Hospital;   Rennes University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2021 Category: Research Source Type: clinical trials